Press release
Hemoglobinopathy Market Forecast Growing at 8.3% CAGR to Reach $1.7 Billion by 2034
Get Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9406
Telemedicine and remote monitoring technologies are increasingly being incorporated into hemoglobinopathy market strategies. By embracing and using these technologies, businesses are putting themselves in a position to maximize operational effectiveness, improve care management, and increase patient accessibility. This deliberate use of telehealth solutions aligns with more general industry developments and addresses the growing need for accessible, patient-focused healthcare services. Businesses strategically using telemedicine can obtain a competitive advantage in the rapidly changing healthcare market.
In the hemoglobinopathy industry, integrating cutting-edge technologies like artificial intelligence (AI) and machine learning is competitively essential. Businesses that use these technologies strategically stand to gain advantages in data analysis, improved diagnosis accuracy, and expedited treatment planning. This deliberate integration responds to the need for efficiency and innovation in technology while aligning with more general healthcare trends. Businesses that strategically adopt technology integration stand to benefit from a competitive edge that will propel them to operational excellence and solidify their leadership in the ever-changing field of hemoglobinopathy treatments.
Key Takeaways from the Hemoglobinopathy Market (혈색소병증 시장) Report
The global hemoglobinopathy market size stood at US$ 2,634.9 million in 2019.
The North America hemoglobinopathy market holds a 20.5% of the market share in 2024.
The East Asia hemoglobinopathy market holds 6.9% of the market share in 2024.
The routine red blood cell (RBC) count test type segment is expected to occupy 28.5% of the market share in 2024.
The diagnostic laboratories segment is estimated to capture 51.7% of the market share in 2024.
The market size in the United States is projected to rise at a 7.6% CAGR through 2034.
The market size in China is anticipated to develop at an 8.7% CAGR through 2034.
Country-wise Insights
Over the course of the projection period, a large expansion of the hemoglobinopathy market in North America is expected. The market for hemoglobinopathy in the US is anticipated to develop at the fastest rate, 7.6% CAGR, until 2034. With an 8.7% CAGR through 2034, China is predicted to lead the East Asia hemoglobinopathy market.
Key Companies Profiled in This Report
Novartis AG
Bluebird Bio, Inc.
Global Blood Therapeutics, Inc.
CRISPR Therapeutics
Editas Medicine
Sangamo Therapeutics
Acceleron Pharma, Inc.
Emmaus Life Sciences, Inc.
Gamida Cell Ltd.
Vertex Pharmaceuticals Incorporated
PTC Therapeutics, Inc.
Kiadis Pharma
Incyte Corporation
Celgene Corporation (acquired by Bristol Myers Squibb)
Lonza Group AG
Orchard Therapeutics plc
Apellis Pharmaceuticals
Regeneron Pharmaceuticals, Inc.
Bluebird Bio, Inc.
Sanofi S.A.
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=9406
Competitive Landscape
The market for hemoglobinopathy is extremely competitive, with prominent companies like Novartis AG and Bluebird Bio at the forefront. These businesses highly value strategic alliances, active R&D, and access to international markets. Observing regulations is essential for receiving permissions on schedule. Companies stand out for their technological leadership, particularly in gene editing. The market is dynamic due to fierce rivalry and an emphasis on innovation.
Recent Developments
In October 2023, Sanguina, Inc. (Sanguina), a leading biotech company, announced that AnemoCheck Home, the only FDA-cleared home hemoglobin test kit available in the United States, had acquired FDA clearance.
In June 2023, Mylab Discovery Solutions announced the PathoCatch Sickle Cell quick test for Sickle Cell Anemia as a strip-based, rapid point-of-care diagnostic. This CDSCO-approved test aims to transform how healthcare practitioners diagnose and manage SCA by giving rapid and reliable results at the patient's location.
Hemoglobinopathy Market (Markt für Hämoglobinopathie) Segmentation
By Test Type :
Routine Red Blood Cell (RBC) Count
Genetic Testing
Hemoglobin by High Performance Liquid Chromatography
Isoelectric
Hemoglobin Solubility Test
By Indication :
Sickle Cell Disease
Beta Thalassemia
Alpha Thalassemia
By End User :
Hospitals
Diagnostic Laboratories
Clinics
By Region :
North America
Europe
Latin America
East Asia
South Asia & Oceania
Middle East & Africa
Contact:
US Sales Office
11140 Rockville Pike
Suite 400 Rockville, MD 20852
United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Sales Team: sales@factmr.com
About Fact.MR :
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hemoglobinopathy Market Forecast Growing at 8.3% CAGR to Reach $1.7 Billion by 2034 here
News-ID: 3475319 • Views: …
More Releases from Fact.MR
USA Demand for Microbiome Skincare Products in USA Outlook 2025-2035: Key Develo …
The U.S. microbiome skincare market is projected to experience rapid, data-driven growth over the next decade, driven by rising consumer awareness, ingredient innovation, and the integration of personalized diagnostics. Analysts estimate the U.S. microbiome skincare segment at approximately USD 0.13 billion in 2025, with a projected increase to USD 0.35 billion by 2035, representing a compound annual growth rate (CAGR) of 10.4%.
To access the complete data tables and in-depth insights,…
USA Demand for Lubricants in USA Outlook 2025-2035: Key Developments and Future …
The U.S. lubricants market is projected to experience steady growth through 2035, driven by shifts in mobility, industrial demand, and sustainability trends. The market was valued at approximately $41.2 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 2.5%, reaching $52 billion by 2035.
To access the complete data tables and in-depth insights, request a Discount On The Report here: https://www.factmr.com/connectus/sample?flag=S&rep_id=12463
…
European Demand for Intermodal Freight Transportation in UK Outlook 2025-2035: K …
"Demand for intermodal freight transport connecting the UK and continental Europe is projected to grow at a CAGR of 6.8% between 2025 and 2035, driven by rising trade volumes, decarbonization mandates, and digital logistics innovations. The intermodal market, encompassing rail, short-sea shipping, and last-mile road delivery, is expected to handle over 18 million TEUs (twenty-foot equivalent units) annually by 2035, up from 10.2 million TEUs in 2025.
To access the complete…
USA Demand for Hydroxyapatite in USA Outlook 2025-2035: Key Developments and Fut …
The United States hydroxyapatite (HAp) market is projected to experience sustained, data-driven growth from 2025 through 2035, fueled by rising clinical demand, technological innovation, and expanded applications in regenerative medicine. Market modeling indicates that U.S. consumption of hydroxyapatite will nearly double over the next decade, with strong adoption in orthopedic, dental, and advanced biomaterial sectors.
To access the complete data tables and in-depth insights, request a Discount On The Report here:…
More Releases for CAGR
[CAGR of 6.7%] Nanocoatings Market Size, Industry Share, CAGR, Regional Forecast …
The global Nanocoatings Market generated $10.7 billion in 2020, and is projected to reach $20.1 billion by 2030, growing at a CAGR of 6.7% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends.
Download sample PDF @ https://www.alliedmarketresearch.com/request-sample/2064
According to the report published by Allied Market Research,…
[CAGR of 5.3%] Pigments Market Size, Industry Share, CAGR, Regional Forecast, 20 …
A recent report by Allied Market Research provides a detailed analysis of the pigments market, highlighting its robust growth. The industry was valued at $27.2 billion in 2022 and is projected to surge to $45.4 billion by 2032, exhibiting an impressive CAGR of 5.3% from 2023 to 2032.
This research report identifies the growth drivers behind the market's expansion and delves into the market dynamics using advanced analytical frameworks…
Enzymes Market Expansion CAGR of 4.9% CAGR Anticipated 2025-2034
The Enzymes Market report is an in-depth examination of the global Enzymes Market's general consumption structure, development trends, sales techniques, and top nations' sales. The research looks at well-known providers in the global Enzymes Market industry, as well as market segmentation, competition, and the macroeconomic climate. A complete Enzymes Market analysis takes into account a number of aspects, including a country's population and business cycles, as well as market-specific microeconomic…
Waterproofing Membranes Market is Projected Grow at CAGR of 8% CAGR by 2033
The waterproofing membranes market is anticipated to witness a Compound Annual Growth Rate (CAGR) of 8.0% over the forecast period. By 2023, the estimated market value for waterproofing membranes is substantial, reaching US$ 31.5 billion.
These waterproofing materials comprise thin, impermeable membranes designed to collaborate with asphalt, providing a protective shield for the structural integrity of buildings. The asphalt component in these membranes acts as a safeguard, preserving the underlying membrane…
Electric Bed Market CAGR, Size, Share Grow USD 2,063 Million by 2030 CAGR 13.70%
Global electric bed market size is expected to be worth roughly USD 2,063 million by 2030, growing at a CAGR of more than 13.7% during the projected timeframe of 2022-2030, according to Ameco Research
A significant portion of the population over the age of 60, who often have reduced immunity levels and are more susceptible to neurological disorders, cardiac issues, tumors, and spinal cord compression, is anticipated to have a substantial…
Pediatric Radiology Market Size will Grow at CAGR 7.7% CAGR during 2017-2026
Pediatric Radiology Market:Overview
The pediatric radiology market is likely to register robust growth in the near future. Chronic illnesses among children including neurological disorders such as ADHD are on the rise. According to the US labor bureau, the demand for pediatrician is expected to grow by 24% on average by 2020. This is the highest average growth among all professionals in the United States.
Despite challenges such as training for new…
